2.14
-0.12 (-5.31%)
-0.12 (-5.31%)
Upgrade to Real-Time
Afterhours (Closed)
Low
1.45
High
6.18
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Hepion Pharmaceuticals Inc | HEPA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.12 | -5.31% | 2.14 | 00:00:08 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.25 | 2.01 | 2.27 | 2.14 | 2.26 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.13 | 3.50 | 1.37 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,929 | 4,459,899 | $ 2.14 | $ 9,543,435 | 1,922,049 | 1.45 - 6.18 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:50:07 | 1 | $ 2.14 | USD |
Hepion Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 163.12M | 76.23M | 76.12M | $ - | $ - | -2.23 | -1.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 4.35M | 1.00% |
Hepion Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HEPA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.79 | 2.30 | 1.77 | 2.09 | 3,730,359 | 0.35 | 19.55% |
| 1 Month | 1.5589 | 2.30 | 1.5503 | 1.88 | 2,009,700 | 0.5811 | 37.28% |
| 3 Months | 2.11 | 2.30 | 1.45 | 1.85 | 2,211,968 | 0.03 | 1.42% |
| 6 Months | 1.81 | 3.18 | 1.45 | 2.11 | 4,161,168 | 0.33 | 18.23% |
| 1 Year | 2.30 | 6.18 | 1.45 | 2.36 | 2,707,920 | -0.16 | -6.96% |
| 3 Years | 3.11 | 8.35 | 1.00 | 2.68 | 1,845,053 | -0.97 | -31.19% |
| 5 Years | 3.11 | 8.35 | 1.00 | 2.68 | 1,845,053 | -0.97 | -31.19% |
Hepion Pharmaceuticals Description
| Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, CRV431, is being developed to offer benefits to address these multiple complex pathologies. CRV431 is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. |
